The parent company of CurrentBody has reported its 2025 results – and it is good news for shareholders.
The Beauty Tech Group plc said in January that it expected revenues and adjusted EBITDA of at least 拢136 million and 拢35.5m respectively, compared with earlier projections of 拢128m and 拢32m.
Today it reported the final results, with total revenue coming in at 拢141m – 39.4% higher than 2024 – and adjusted EBITDA of 拢37.5m (+63.8%).
The Cheshire firm launched on the London Stock Exchange in October with a share price of 271 pence 鈥� valuing it at 拢300m.
It is down slightly in trading today but up 7% in the year to date and 8% on its IPO price.
The group owns brands including CurrentBody Skin, ZIIP Beauty and Tria Laser, which are used by stars such as Serena Williams and Kim Kardashian.
It said this morning that CurrentBody Skin revenue grew 59% to 拢125.8m, while ZIIP Beauty revenue grew 46% to 拢13.2m and Tria Laser contributed 拢2m.
All external debt has been fully repaid, the firm said, leaving it debt-free, and it claimed it has witnessed a 鈥渧ery encouraging start to Q1 FY26鈥�.
CEO Laurence Newman said: “2025 was a transformational year for The Beauty Tech Group and I am pleased to report our maiden full year results.聽
鈥淭he strong financial and operational performance significantly exceeded our initial expectations set out at IPO.聽
鈥淭hese [record] results demonstrate that our market-leading brands and products are gaining increasing recognition with customers, and our targeted go-to market strategy and international footprint provide a solid platform for sustainable growth.
“Looking ahead, the structural growth drivers across the group’s three core addressable markets of anti-ageing, hair removal and hair regrowth, provide us with confidence in both the long-term demand for at-home beauty devices and The Beauty Tech Group’s significant market opportunity.聽
鈥淥ur investment in clinical research and independent third-party product validation reinforces our position as the leading specialist in at-home beauty technology. We have a strong pipeline of innovative product development across our three brands and I am confident that the group is well placed to deliver long-term profitable growth for shareholders.”